drugset / Trial / NCT02312440

Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty

NCT02312440

Phase 3 Completed 173 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Recently, there has been interest in applying tranexamic acid topically before the closure of surgical wounds in total hip replacement. It has the advantages of ease of application, maximum concentration at the site of bleeding, minimising its systematic absorption and, potentially , decline the risks for systematic side-effects 。

Timeline

Start
2014-10
Primary completion
2015-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous
Subject Tranexamic Acid Small molecule 3 g Intravenous

Indications

No indication recorded.